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"The poorest of all laboratory work is that done 
in the private physician's office." That allegation was 
made by the Director of the New York City Depart-
ment of Health Bureau of Laboratories in a state-
ment to a Senate Committee of the Judiciary Com-
mittee on Antitrust and Monopoly on February 7, 
1967 ( 1). Statements such as this typify the public 
relations problem facing directors of office labora-
tories today. The problem is twofold: First, how can 
the quality of the office laboratory be assured and 
documented? Second, how can this information be 
disseminated to legislators and the general public? 
The first is an easily solved technical problem toward 
which this paper is directed. The second and prob-
ably the most difficult is a media problem beyond 
the scope of a technical journal. 
Laboratory quality assurance and documentation 
are best considered as a subset of the more general 
field of quality control, an industrial discipline with 
its roots in the industrial revolution. Industrial qual-
ity control is the technique, for instance, whereby 
the automotive industry may precisely design ob-
solescence into an automobile without impinging on 
the warranty period in order to maximize profits. 
Quality control in the drug industry assures not only 
that the amount of drug in a pill falls within accept-
able tolerances but that the pill itself is not mal-
formed. A malformed pill results in very bad public 
relations for the drug company, even if its function is 
not impaired. The pigeon, an animal with a very 
fine eye for detail, has been used successfully for 
assembly line quality assurance in removing faulty 
pills prior to packaging (2). Laboratory medicine 
also produces a product which can be subjected to 
quality control, the laboratory result . 
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Error Frequency Distributions. Any discussion 
of laboratory quality control should begin with a 
brief account of practical statistics, since statistics is 
the science whereby a decision can be made as to 
whether a laboratory result is acceptable or unac-
ceptable. An introduction to these statistics should 
begin with the error frequency distribution. 
If a unit of outdated blood bank blood is mixed 
well and dispensed into 100 test tubes, this set of 
tubes is called a "pool." The plasma glucose content 
of any one of these tubes is the same as that of any 
other, since all tubes came from the same bag of 
blood. If one attempts to assay each of those 100 
tubes of blood for glucose, however, the assay re-
sults will not be identical for all tubes. Some will be 
above an average value and some below, as shown 
in the histogram in figure 1. A few results will deviate 
markedly from the average value but most will 
cluster around the average. The smooth curve (some-
times called Gaussian or bell-shaped) drawn through 
the steps of the histogram is called a frequency dis-
tribution plot, and it can be used to make a decision 
as to when a laboratory result deviates too far from 
the average value of the pool. If one calculates a so-
called standard deviation (SD), one can define loca-
tion of the cutoff point between acceptable and 
unacceptable results. The use of the standard devia-
tion has two advantages over a single intuitive guess 
about where the line between good and bad data 
lies. First, use of the standard deviation (actually ± 
2SD) as a decision point guarantees that 95 % of the 
results will be in the acceptable range on the average. 
Second, standard deviation is used by most prac-
titioners of laboratory medicine and is understood by 
them, thereby providing a common ground for dis-
cussion. It might be mentioned that the frequency 
distribution plot shown in figure 1 is a real life situa-
tion. That is, it is technically impossible to get 
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Fig. I-Frequency histogram of Gaussian distribution with 
overlying frequency distribution plot. Note that the majority 
of values cluster around the peak of the curve. 
identical results for the plasma glucose in each of 
those 100 tubes. One can use more costly and dif-
ficult methods and the range on the horizontal axis 
will narrow, but the results cannot be made identical. 
This means that there is no "true" value for the 
glucose in the plasma. Analytical balances used for 
weighing the glucose also have error frequency 
distributions. 
Frequency Distributions of Normal Patient 
Laboratory Determinations. Figure 2 shows the re-
sults obtained for blood urea nitrogen determined on 
each of 495 "healthy" patients plotted in the same 
fashion as the pool results in figure 1. As might be 
expected, most of the results cluster around an aver-
age value with a few markedly deviant values to the 
left and right of center. Notice that the frequency 
distribution plot is skewed with more deviant values 
to the right (occult disease?) than to the left. This 
is because there is no such thing as a negative blood 
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Fig. 2-Urea nitrogen frequency distribution plot. Notice 
that there are far more deviant results on the high side of 
the curve than on the low side; that is, the curve is skewed. 
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urea nitrogen, so the curve is steeper on the left than 
on the right. 
Now, suppose one took a large number of 
patients with renal disease, drew their blood, per-
formed a blood urea nitrogen on them, and super-
imposed their frequency distribution plot on an 
idealized plot of the frequency distribution of urea 
nitrogen of "normal" patients (fig. 3). How might 
one define the upper limits of "normal" using this 
data? One might draw a vertical line at the lowest 
point between the normal peak and the sick peak 
and call this the upper limit of normal. It is obvious, 
however, that the two curves overlap and in the areas 
of overlap, some normal patients will be called sick 
when they are not, and some sick patients will be 
called normal when they are not. Anyone experi-
enced with the SMA 12-60 has seen elevated uric 
acids in perfectly normal people who never develop 
gout. To further complicate things, a large labora-
tory error component will tend to broaden this range 
of ambiguity to an even greater extent. 
Effect of Methodology on Normal Ranges. Fig-
ure 4 shows frequency distribution plots of two dif-
ferent assay methods for blood glucose-the glucose 
oxidase and the ferricyanide methods. The glucose 
oxidase method is a so-called "true glucose" method 
and produces comparatively low results, partly be-
cause it is subject to inhibition by some patients' 
blood. The classical ferricyanide glucose method, on 
the other hand, produces comparatively high results 
because it measures not only true glucose but also 
other reducing substances such as fructose and 
glyceraldehyde. From the point of view of the patient 
and his physician, the important thing is the normal 
range. The glucose oxidase blood glucose normal 
range is 10-20 mg percent lower than that of the 
ferricyanide method. If one used both methods 
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Fig. 3- Superimposed frequency distribution plots of nor-
mal and abnormal urea nitrogen determinations. Note the 
area of ambiguity or overlap between the sick and the well 
person. 
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Fig. 4-Frequency distribution plots for two different blood 
glucose methods. Note that the normal range is different for 
each. 
simultaneously, one would widen the normal range 
as shown in the composite curve in figure 4 and a 
substantial increase in false negative blood glucose 
results would occur. This could easily happen if two 
different kits using different methodology were used 
interchangeably. The result would be a component 
of laboratory error which would widen considerably 
the range of ambiguity of the blood glucose data. 
Effect of Methodology on "Biologic Variation." 
Figure 5 is a time-course plot of the blood sodium 
level of the author drawn over a period of a month. 
The upper curve (JHR) represents the human blood; 
the two lower curves (Control 1 and Control 2) are 
two commercial pools assayed simultaneously with 
the human blood. Had there been no laboratory 
error, the lower plots (Control 1 and Control 2) 
would be perfectly straight lines parallel to the hori-
zontal axis. Note that the two curves are sawtooth 
instead, describing day-to-day laboratory error. Be-
cause of within-day random error, or perhaps be-
cause of pipetting error they are not exactly parallel 
to one another. The most striking feature of 
figure 5 is that the human serum drawn on the same 
day shows the same pattern of variation. The im-
plication is that a substantial component of so-called 
"biologic variation" for serum sodium actually is 
laboratory error. Carefully controlled studies such as 
this, in fact, indicate that the flame photometer is 
incapable of measuring the subtle changes of biologic 
variation and that, in fact, all variations measured 
in normal human blood sodium are actually labora-
tory error not biologic variation. Many other blood 
components, potassium, for example, show similar 
effects of day-to-day laboratory error. If one could 
reduce the day-to-day error component in measuring 
blood sodium, one might be able to pick up more 
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subtle changes, the normal range would undoubtedly 
shrink and fewer false negative and false positive 
results would occur. The cost of increased accuracy 
and precision, however, is prohibitive at present. 
Setting of Control Limits and the Effect on 
Patient Care. Figure 6 is a graphic example of the 
effect of control limits set too wide in the laboratory. 
Bilirubin is traditionally a poor test from an ac-
curacy standpoint because of the difficulty of main-
taining adequate standards which will not deterio-
rate. The error shown in figure 6, however, is caused 
by an improperly calibrated reference serum used 
to calibrate the SMA 12-60 bilirubin. On day 20, 
the laboratory used the last of a particular manufac-
turer's reference serum and began to use a new lot 
from a different manufacturer. The effect was an 
abrupt increase in every normal patient's bilirubin 
of 0.4 mg percent and an increase in the bilirubin 
of the patients in the moderately elevated range of 
0 .7 mg percent. Obviously the normal range was 
widened by this change. Tighter control limits would 
have detected this change sooner. Furthermore, an 
alert visual scan by a physician of the patient results 
for the day would have proven to be an extremely 
useful form of quality control. It was concluded that 
one could not rely upon the manufacturer's brochure 
provided with the lots of reference serum. 
Some Simple Techniques for Quality Control. 
One of the oldest forms of laboratory quality control 
is the "repeat." If one doubts the validity of the 
first result, send another one and compare the two. 
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Fig. 5-Time course plot of the blood sodium level of the 
author drawn over a period of 30 days. The upper curve 
represents the human blood (JHR). The lower curves (Con-
trol 1 and Control 2) represent pooled control sera. The 
parallel variation indicates that the greater part of the "di-
urnel variation" of the human sodium actually represents 
analytical variation. 
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Fig. 6-The effect of a change of control pool manufacturer 
on day 20. Notice the striking change in levels of bilirubin 
for the control pool. 
This is of no use, however, if a very poor laboratory 
is very good at reproducing its bad results on repeats. 
The split sample is a slightly more sophisticated 
form of the repeat. In this case, the original sample 
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is mixed well and divided into two parts. A phony 
name is attached to one specimen and the second 
member is submitted to the laboratory sometime 
later. This technique is designed to foil the labora-
torian who claims that "biologic variation" caused 
the difference in the two results. A rule of thumb for 
the split sample is that if the results of the two split 
samples vary by more than 10% the results are 
suspect. This figure varies from test to test. The 
split sample is also useful in those tests for which 
reference standards are not yet available such as 
urinalysis, bacteriology and even some coagulation 
studies. 
Another more complex method of quality con-
trol is the mixed specimen. This works best with 
blood chemistries. If you mix known amounts of 
each of two patient specimens, the results of all 
components ( excluding enzymes) will be proportional 
to the original concentrations and volumes mixed. 
The calculation for the predicted results is fairly 
straightforward. 
Most people rapidly tire of the exercise of pre-
paring their own quality control samples and pur-
chase these from some national program such as 
the Proficiency Evaluation Program (PEP) for the 
Physician's Office Laboratory. 
Proficiency Evaluation Program for the Physi-
cian's Office Laboratory. Beginning in April, 1973, 
the College of American Pathologists and the Ameri-
can Society of Internal Medicine are jointly sponsor-
ing a quality control program designed specifically 
for the physician's office laboratory. The data ob-
tained are treated in an entirely confidential manner 
and meet the demands of public health agencies, 
legislators, professional associations and patients for 
a third party evaluation of the office laboratory. 
Quarterly kits are mailed out to subscribers contain-
ing seven vials of test unknowns and a blood smear. 
These vials contain material for evaluating hemo-
globin, red cell counts, hematocrit, glucose, bilirubin, 
cholesterol, urea, uric acid, urine specific gravity, 
urine protein, urine reducing substance, urine bili-
rubin, urine hemoglobin, urine pH, prothrombin 
time, white cell count, urine bacteriology and periph-
eral smear. One hundred tests per year are per-
formed on a quarterly basis and mailed into the 
testing agency for evaluation. Four weeks after re-
ceipt, results from all subscribing laboratories are 
pooled, processed by computer, and a computer 
print out is mailed to all subscribers giving name of 
constituent, method used, subscriber's result pass or 
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fail code, average of all laboratories for comparison, 
a good performance range and an acceptable per-
formance range. In addition, a quarterly bulletin is 
sent to all subscribers, describing findings and includ-
ing a personalized certificate for wall-mounting. 
The advantages of such a system are apparent. 
First, the director gets a confidential warning that 
his laboratory is having difficulty, thus giving him 
the opportunity to correct the difficulty. Comparison 
of results with peers is always informative as to the 
wide interlaboratory differences. The effort expended 
is minimal and does not disrupt the normal func-
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tion of the laboratory and the cost is far less than 
manual preparation of samples and data collection. 
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